Office Action Predictor
Application No. 17/487,246

FLUOROPOLYETHER GROUP-CONTAINING COMPOUND

Non-Final OA §102
Filed
Sep 28, 2021
Examiner
NGUYEN, HA S
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Daikin Industries, LTD.
OA Round
3 (Non-Final)
57%
Grant Probability
Moderate
3-4
OA Rounds
3y 4m
To Grant
46%
With Interview

Examiner Intelligence

57%
Career Allow Rate
339 granted / 597 resolved
Without
With
+-10.6%
Interview Lift
avg trend
3y 4m
Avg Prosecution
48 pending
645
Total Applications
career history

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
39.1%
-0.9% vs TC avg
§102
25.5%
-14.5% vs TC avg
§112
20.2%
-19.8% vs TC avg
Black line = Tech Center average estimate • Based on career data

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 09/09/2025 has been entered. Claims 1-9 are pending and being examined. Response to Amendment The previous rejection is modified and maintained in light of the Applicant’s amendments and arguments. Claim Rejections - 35 USC § 102/103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 1-9, is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by US 2021/0348025 A1 to Shiota. (hereinafter Shiota). Regarding claims 1-9, Shiota teaches a fluorinated ether composition comprising the compound (1) having the formula (1) PNG media_image1.png 109 272 media_image1.png Greyscale , and compound (2) having the formula (2) PNG media_image2.png 127 460 media_image2.png Greyscale , (para 10-23), and further containing a fluorinated oil (para 23). Shiota teaches also teaches a method of treating the surface of a substrate by coating the substrate with the said fluorinated ether composition. (para 10-23). For formula (1) PNG media_image1.png 109 272 media_image1.png Greyscale Shiota teaches: A11 is a perfluoroalkyl group (para 40), with CF3- as a specific example, (para 47 and example compound (1-1), para 131), which meets the claimed Rf1 as CF3-; (OX11)m11 contains two more types randomly ordered units and particularly preferable are (OCF2) and (OCF2CF2) (para 56-57), and wherein the portion of (OCF2CF2) (i.e. claimed unit e), to (OCF2) (i.e. claimed unit f), is preferably 0.2-5, (para 57), which meets the claimed e/f ratio cited in claims 1 and 3, and for formula (2), wherein m21 is 2-200, (OX12) is similar to the above (OX11) and m11 of compound 1 (para 75-83), and Q13 is a single bond, (para 47); and the PNG media_image3.png 141 136 media_image3.png Greyscale portion of formula (1) is specifically PNG media_image4.png 120 181 media_image4.png Greyscale (See compound (1-2), para 137-1380; and which also meets the claimed e/f ratio cited in claims 1 and 3, claim 2 wherein c and d are 0. Thus, the above formula (1) of Shiota meets the claimed formula (1) because one skilled in the art would at once envisage the claimed arrangement combination because, as shown above, Shiota specifically teaches an arrangement that meets the claimed formula (1) wherein CF3-(OCF2CF2)-(OCF2)-meets RF1, and PNG media_image4.png 120 181 media_image4.png Greyscale meets the –(C=O)-NRSi2 portion of claimed formula (1), and also teaches the claimed e and f are at least 1, with the claimed e/f range, and wherein a, b, c and d are 0. (See MPEP 2131.02). Shiota further teaches formula (1) is specifically compound (1-2) PNG media_image5.png 126 595 media_image5.png Greyscale , wherein m5 is 21 and m6 is 20, and a MW of 4540, (para 137-138), which gives a specific example of the claimed e/f and correlates to an e/f of 0.95, which meets the claimed range. Shiota also teaches formula (2) is specifically compound (2-2) PNG media_image6.png 131 563 media_image6.png Greyscale wherein the above is obtained from Fluorolink D4000, where it is known in the art for m7 and m8 are in about 1:1 ratio, (i.e. m8 is about 22 and m7 is about 22), m7+m8 is 44, and a MW of 4755 (para 151 and 159), which correlates to an e/f of 1, which meets the claimed range. Shiota further teaches the fluorinated oil is FOMBLIN M15, which has the formula (3-1) PNG media_image7.png 28 198 media_image7.png Greyscale , wherein m9+m10 is 105, and a MW of 9700, (para 161-162). Shiota also teaches a composition containing a total mol% ratio of compound 1 to compound 2 is 70 mol% of compound (1-2) and 30 mol% of compound (2-2), and the fluorinated oil (3-1) in an amount of 25 mass% of the composition (Table 1, example 16, para 163). Using the above amounts, this correlates to about 6.31 mols of fluorinated oil, 70 mols of compound (1-2), and 30 mols of compound (2-2), 106.31 total mols, and 28.2 mol% of compound (2), and 5.9 mol% of fluorine-containing oil based on the total of compound (1), compound (2) and fluorine-containing oil, and meets claim 8. Response to Arguments Applicant's arguments filed 09/09/2025 have been fully considered but they are not persuasive. On page 8-9, the Applicant argues that Shiota does not teach the claimed fluoropolyether group-containing compound of formula (1), particularly RF1 is CF3-(OC6F12)a-(OC5F10)b-(C4F8)c-(OC3RFa6)d-(OC2F4)e-(OCF2)f-. This is not persuasive because, for the claimed RF1, when q=0, a=0, b=0, c=0, d=0, RF1 will have the formula CF3-(OC2F4)e-(OCF2)f-. As cited above, Shiota teaches that PNG media_image8.png 41 130 media_image8.png Greyscale portion of the formula: A11 is a perfluoroalkyl group (para 40), with CF3- as a specific example, (para 47 and example compound (1-1), para 131), which meets the claimed Rf1 as CF3-; (OX11)m11 contains two more types randomly ordered units and particularly preferable are (OCF2) and (OCF2CF2) (para 56-57), and wherein the portion of (OCF2CF2) (i.e. claimed unit e), to (OCF2) (i.e. claimed unit f), is preferably 0.2-5, (para 57), which meets the claimed e/f ratio cited in claims 1 and 3,and Q13 is a single bond, (para 47). From the above teaching, this correlates PNG media_image8.png 41 130 media_image8.png Greyscale to be the formula CF3-(OC2F4)0.2-5-(OCF2)0.2-5-, which meets RF1 formula CF3-(OC2F4)e-(OCF2)f-. Thus, the above PNG media_image8.png 41 130 media_image8.png Greyscale of Shiota meets the claimed RF1 because one skilled in the art would at once envisage the claimed arrangement combination because, as shown above, Shiota specifically teaches an arrangement of the formula CF3-(OC2F4)0.2-5-(OCF2)0.2-5- that meets the claimed RF1 formula, when q=0, a=0, b=0, c=0, d=0, of CF3-(OC2F4)e-(OCF2)f- and also teaches the claimed e and f are at least 1, with the claimed e/f range. (See MPEP 2131.02). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HA S NGUYEN whose telephone number is (571)270-7395. The examiner can normally be reached Mon-Fri, Flex schedule 7:30am-3:45pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at (571)272-1302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HA S NGUYEN/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Sep 28, 2021
Application Filed
Aug 26, 2024
Non-Final Rejection — §102
Dec 17, 2024
Applicant Interview (Telephonic)
Dec 17, 2024
Examiner Interview Summary
Feb 27, 2025
Response Filed
May 06, 2025
Final Rejection — §102
Sep 09, 2025
Request for Continued Examination
Sep 16, 2025
Response after Non-Final Action
Sep 23, 2025
Non-Final Rejection — §102
Apr 01, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology. Study what changed to get past this examiner.

Patent 12595333
CURABLE ADHESIVE, BONDING FILM, AND METHOD OF BONDING THE SAME
2y 5m to grant Granted Apr 07, 2026
Patent 12595334
COMPOUND, MIXTURE, CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING COMPOUND
2y 5m to grant Granted Apr 07, 2026
Patent 12590222
TWO-COMPONENT POLYURETHANE COATING COMPOSITION, COATING FORMED FROM THE TWO-COMPONENT POLYURETHANE COATING COMPOSITION AND COATED ARTICLE
2y 5m to grant Granted Mar 31, 2026
Patent 12583963
POLYMERIZABLE COMPOSITION AND OPTICAL MATERIAL USING THE SAME
2y 5m to grant Granted Mar 24, 2026
Patent 12577348
PLASTICIZER AND METHOD FOR MANUFACTURING THE SAME
2y 5m to grant Granted Mar 17, 2026

AI Strategy Recommendation

Click below to generate an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
57%
Grant Probability
46%
With Interview (-10.6%)
3y 4m
Median Time to Grant
High
PTA Risk
Based on 597 resolved cases by this examiner